Biocon

The Board has approved the raising of funds up to Rs 4,500 crore via the issuance of equity shares, non-convertible debt instruments along with warrants, by way of qualified institutions placement(s), rights issue, preferential allotment, or private placement(s), in one or more tranches.

Bharat Petroleum Corporation

BPCL has entered into a joint venture (JV) agreement with GPS Renewables to establish compressed biogas (CBG) plants across India. This strategic alliance marks a significant step towards advancing India’s energy transition and contributes to BPCL’s net-zero goals.

Adani Green Energy

The company’s subsidiary, Adani Hydro Energy Five, has entered into a Power Purchase Agreement (PPA) with Uttar Pradesh Power Corporation (UPPCL) for the supply of 1,250 MW of energy storage capacity from pumped hydro storage projects.

Niva Bupa Health Insurance Company

The Insurance Regulatory and Development Authority of India (IRDAI) has approved the re-appointment of Krishnan Ramachandran as the CEO and Managing Director of the company for five years, effective May 1.

S&S Power Switchgear

Sivakumar S has resigned as Chief Financial Officer (CFO) of the company due to personal reasons, effective April 23.

Panacea Biotec

The company has received an additional award worth $5.2 million (approximately Rs 44 crore) from UNICEF for the supply of 40 million doses of its bivalent oral polio vaccine (bOPV) in Q3 CY2025. In December 2024, it had received an award worth $14.95 million (approximately Rs 127 crore) for the supply of 115 million doses of its bOPV in CY2025.

Spandana Sphoorty Financial

Shalabh Saxena has resigned as Managing Director and Chief Executive Officer of the company, effective April 23. The Board has approved the appointment of Ashish Kumar Damani as the Interim Chief Executive Officer of the company, effective April 23. Ashish Kumar Damani is currently designated as President and Chief Financial Officer of the company.

Bajaj Finance

The Board will meet on April 29 to additionally consider a special (interim) dividend for FY25, the sub-division/split of existing equity shares, and the issue of bonus shares, along with financial results.

Max India

The Board has approved the issue price at Rs 150 per equity share for its rights issue worth Rs 125 crore. The rights entitlement ratio is 19 rights equity shares for every 100 equity shares held by eligible shareholders as of the record date of April 29. The rights issue will open on May 7 and close on May 22.

Embassy Office Parks REIT

The Board has approved the raising of funds up to Rs 6,500 crore via debt and the issuance of commercial papers worth Rs 675 crore.

LTIMindtree Q4 (Consolidated QoQ)

Profit rises 3.97% to Rs 1,128.5 crore Vs Rs 1,085.4 crore. Revenue increases 1.1% to Rs 9,771.7 crore Vs Rs 9,660.9 crore. EBIT margin stands steady at 13.8% Vs 13.8%. Revenue in dollar terms declines 0.7% to $1,131 million Vs $1,138.7 million. Board recommends a final dividend of Rs 45 per share.

Tata Consumer Products Q4 (Consolidated YoY)

Profit zooms 59.2% to Rs 344.9 crore Vs Rs 216.6 crore. Revenue grows 17.3% to Rs 4,608.2 crore Vs Rs 3,926.9 crore. Exceptional gains at Rs 45.32 crore Vs exceptional loss of Rs 215.8 crore. Board recommends a dividend of Rs 8.25 per share for FY25.

Vikasdhan - Grow your Dhan with Vikasdhan

Disclaimer- not an investment advice, only for educational purpose. To read complete disclaimer, click on the link https://www.vikasdhan.com/disclaimer